20:49 , May 24, 2019 |  BioCentury  |  Finance

How Europe’s hotspots of innovation could fuel its rise as a global player in new modalities

It is clear that Europe has hotspots of innovation that are discovering and developing the next wave of new therapeutic modalities. Nearly every category of new modality has a European champion, with clusters forming around...
22:38 , Mar 19, 2019 |  BC Extra  |  Company News

Management tracks: Medicines Co., Mallinckrodt, ArQule

The Medicines Co. (NASDAQ:MDCO) terminated the employment of Christopher Cox, EVP and chief corporate development officer, effective March 15. Details were not disclosed. Mallinckrodt plc (NYSE:MNK) hired Bryan Reasons as CFO. He will succeed interim...
22:52 , Jan 15, 2019 |  BC Week In Review  |  Company News

AZ's Bohen departing after cancer-focused tenure

AstraZeneca plc (LSE:AZN; NYSE:AZN) said Sean Bohen is leaving as CMO and EVP of global medicines development after a tenure marked by mixed results for the pharma's checkpoint inhibitor. Shortly after Bohen joined the pharma...
23:49 , Jan 14, 2019 |  BC Extra  |  Company News

AZ's Bohen departing after cancer-focused tenure

AstraZeneca plc (LSE:AZN; NYSE:AZN) said Sean Bohen is leaving as CMO and EVP of global medicines development after a tenure marked by mixed results for the pharma's checkpoint inhibitor. Shortly after Bohen joined the pharma...
17:24 , Sep 14, 2018 |  BC Week In Review  |  Company News

Community cancer play OneOncology launches with $200M from General Atlantic

OneOncology Inc. (Nashville, Tenn.) launched on Sept. 12, backed with more than $200 million from General Atlantic that the newco will use to develop a data and technology platform to support community-based cancer care. On...
18:24 , Sep 12, 2018 |  BC Extra  |  Company News

Community cancer play OneOncology launches with $200M from General Atlantic

OneOncology Inc. (Nashville, Tenn.) launched on Wednesday, backed with more than $200 million from General Atlantic that the newco will use to develop a data and technology platform to support community-based cancer care. On a...
21:08 , Aug 2, 2018 |  BC Extra  |  Company News

Management tracks: Omeros, EdiGene

Omeros Corp. (NASDAQ:OMER) hired Eckhard Leifke as CMO and VP of clinical development. He was global project head/VP of early project and external opportunities - cardiovascular and metabolism and global head/VP of late-stage development diabetes...
23:07 , Feb 8, 2018 |  BC Innovations  |  Finance

External rethink

As the industry seeks to develop new ways to access external innovation, companies are re-evaluating the value of public-private partnerships, and increasingly turning to other companies for research partnerships in lieu of broad deals with...
17:13 , Dec 15, 2017 |  BC Week In Review  |  Financial News

Ginkgo raises $275M series D round

Ginkgo Bioworks Inc. (Boston, Mass.) raised $275 million in a series D round on Dec. 14. All previous investors participated, including Viking Global, Y Combinator's Continuity Fund and Bill Gates' Cascade Investments. New investor General...
20:52 , Dec 14, 2017 |  BC Extra  |  Financial News

Ginkgo raises $275M series D round

Ginkgo Bioworks Inc. (Boston, Mass.) raised $275 million in a series D round on Thursday. All previous investors participated, including Viking Global, Y Combinator's Continuity Fund and Bill Gates' Cascade Investments. New investor General Atlantic...